Pyxis Oncology, Inc. (PYXS)
1.515
0.00 (0.00%)
USD |
NASDAQ |
Feb 26, 16:00
1.515
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Research and Development Expense (Quarterly) : 17.35M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.499B |
| Xtant Medical Holdings, Inc. | 0.634M |
| Spero Therapeutics, Inc. | 8.597M |
| Processa Pharmaceuticals, Inc. | 1.662M |
| Alpha Teknova, Inc. | 0.542M |